Healthcare Services

Cardiac Troponin Market Revenue Growth Expected to Reach $6.92 Billion by 2030 with 10.3% CAGR

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cardiac Troponin Market In 2026 And What Value Is Projected For 2030?

The cardiac troponin market size has exhibited significant growth in recent years. It is projected to increase from $4.24 billion in 2025 to $4.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. The historical expansion of this market can be linked to factors such as the increasing prevalence of acute coronary syndromes, the expansion of emergency cardiac care services, the adoption of biomarker-based diagnostics, improvements in laboratory testing accuracy, and the growth of hospital diagnostic infrastructure.

The cardiac troponin market is projected to experience swift expansion over the coming years. This market is set to reach a valuation of $6.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. The anticipated expansion during this forecast period stems from several factors, including the escalating need for quick cardiac diagnostic methods, the increasing embrace of decentralized testing approaches, the broader availability of home-based cardiac monitoring, the expanding utilization of AI-assisted diagnostic analysis, and a heightened emphasis on strategies for early intervention. Concurrently, key developments expected within this period encompass the wider acceptance of high-sensitivity troponin assays, the increasing deployment of point-of-care cardiac testing, the growing incorporation of automated laboratory diagnostics, the broadening of rapid rule-in and rule-out procedures, and a sharpened focus on detecting early signs of cardiac injury.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18986&type=smp

What Major Drivers Are Influencing Demand In The Cardiac Troponin Market?

The rising occurrence of cardiac ailments is projected to boost the expansion of the cardiac troponin market in the future. These cardiac conditions include various cardiovascular disorders such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, which impact the heart’s structure and operational capabilities. The growing incidence of heart conditions stems from factors like an aging demographic, inactive lifestyles, unhealthy eating patterns, and increasing levels of obesity and high blood pressure. Cardiac troponin plays a vital role in the diagnosis of heart conditions, acting as a very sensitive biomarker for identifying damage to heart muscle, especially during heart attacks and other cardiac incidents. For instance, October 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, in 2023, 919,032 people died from cardiovascular disease. That’s the equivalent of 1 in every 3 deaths. Consequently, the expanding occurrence of heart conditions will fuel the growth of the cardiac troponin market.

What Are The Key Segments Of The Cardiac Troponin Market?

The cardiac troponin market covered in this report is segmented –

1) By Type: Troponin I, Troponin T

2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing

3) By Application: Acute Coronary Syndrome, Myocardial Infraction

4) By End User: Hospitals, Diagnostic Centers

Subsegments:

1) By Troponin I: Conventional Cardiac Troponin I (cTnI), High-Sensitivity Cardiac Troponin I (hs-cTnI)

2) By Troponin T: Conventional Cardiac Troponin T (cTnT), High-Sensitivity Cardiac Troponin T (hs-cTnT)

How Are Trends Impacting The Cardiac Troponin Market?

Major companies operating in the cardiac troponin market are concentrating on advancing new technology, such as human serum-based quality control, to guarantee accurate and reliable high-sensitivity troponin testing by offering multi-analyte controls. Human serum-based quality control in cardiac troponin testing secures test accuracy and reliability by utilizing human serum with known troponin concentrations to verify the assay’s performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology research company, introduced Cardiac Advance, a four-level, multi-analyte quality control specifically designed for high-sensitivity troponin testing. These liquid, human-serum-based controls are provided in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls encompass 10 cardiac analytes, including troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with Siemens and Roche testing platforms. The products are available in the U.S., Europe, and selected Asian markets.

Who Are The Leading Companies Operating In The Cardiac Troponin Market?

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

Read the full cardiac troponin market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Cardiac Troponin Market?

North America was the largest region in the cardiac troponin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Troponin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18986&type=smp

Browse Through More Reports Similar to the Global Cardiac Troponin Market 2026, By The Business Research Company

Cardiovascular Implants Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Medical Engineered Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Cardiac Prosthetic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795